FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma. (December 2012)

• Record Type: Journal Article
• Authors: Paidpally, Vasavi; Chirindel, Alin; Lam, Stella; Agrawal, Nishant; Quon, Harry; Subramaniam, Rathan M
• Is Part Of: Imaging in medicine. Volume 4:Number 6(2012)
• Page Start: 633
• Page End: 647
• Publication Date: 2012-12
• Subjects: FDG -- head and neck squamous cell carcinoma -- imaging biomarkers -- PET/CT; Diagnostic imaging -- Periodicals; 616.075405
• DOI: 10.2217/iim.12.60
• Languages: English
• ISSNs: 1755-5205

Abstract

This article discusses the value of 18 F-fluoro-2-deoxyglucose PET/CT imaging biomarkers in head and neck squamous cell carcinoma. 18 F-fluoro-2-deoxyglucose PET/CT is valuable at baseline staging, radiotherapy planning, therapy response assessment and in the follow-up of patients with head and neck squamous cell carcinoma. Maximum and peak standardized uptake value (SUVmax and SUVpeak ), metabolic tumor volume and total lesion glycolysis are the common 18 F-fluoro-2-deoxyglucose quantitative parameters that have been studied, along with qualitative assessments. These parameters will be evaluated with respect to their established or potential role as noninvasive biomarkers for patient risk stratification, treatment response and survival outcome.